SEC Form 4 · accession 0001493152-18-006281
Adhera Therapeutics, Inc. · ATRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philippe Calais
Other
Period of report
May 2, 2018
Accepted (ET)
May 4, 2018 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000737207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $0.98 | May 2, 2018 | A | 80,000 | A | May 2, 2018 | May 2, 2023 | common stock | 80,000 | 80,000 | D |